American Well Corp — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 52/100
What the filing says
American Well reported Q2 2026 revenue of $52.0M (at top of guidance), with subscription revenue of $25.7M and AMG visit revenue of $24.4M. Net loss improved to ($9.6M) from ($10.3M) in Q1 2026; Adjusted EBITDA improved to ($1.2M) from ($3.1M) Q1. Company raised FY2026 revenue guidance low end from $195M to $200M–$205M and improved Adjusted EBITDA guidance from ($16M)–($12M) to ($9M)–($7M). Subscription revenue now ~50% of total. No debt; positive operating cash flow projected Q4 2026. DHA (Defense Health Agency) intent to make Amwell a prime contractor announced.
Why this rating
Sequential improvement and guidance raise are constructive, but company is $125M market cap burning $1–9M EBITDA quarterly, losses narrow but persist. Event material but not trajectory-changing.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.